Vagus nerve stimulation reduced inflammation and restored cognitive function after injury
For adults over age 65, surgical complications can dampen not only their physical health but also their mental sharpness, with more than half of high-risk cases declining into delirium.
In research published this week in the journal Brain Stimulation, Duke University scientists show in a mouse model that a current treatment for seizures can also reverse brain inflammation, such as inflammation after surgery, and the subsequent confusion or cognitive decline that results.
The therapy involves minimally invasive stimulation of the vagus nerve using small electrical pulses comparable to a cell phone’s vibrations.
The scientists used a Doppler ultrasound to guide the placement of a needle that delivers the electrical pulse, avoiding nearby delicate structures such as the carotid artery. Researchers hope to refine the technique into a completely non-invasive approach to preventing cognitive decline when seniors and other at-risk patients have surgery.
“Delirium is now recognized as the most common complication in older adults after surgery,” said Niccolò Terrando, Ph.D., associate professor of anesthesiology at Duke and the study’s senior author. “For most patients, it lasts a few days and resolves on its own. For some, it can lead to severe complications and even contribute to long lasting cognitive deficits, like dementia.”
Terrando noted that these cognitive complications have a huge impact on quality of life and can be expensive, with health care costs for delirium reaching $164 billion a year according to the American Society of Anesthesiologists.
“So far, there is no therapy for this kind of cognitive complication after surgery,” Terrando said. Anti-inflammatory drugs have many side effects and work broadly, he said, and they don’t adequately target the inflammation in the brain that scientists believe triggers cognitive complications.
The vagus nerve helps the brain communicate with the heart, lungs, gut and other parts of the body. Vagus nerve stimulators have been surgically implanted in epilepsy patients for more than 20 years to reduce seizures.
In recent years, U.S. doctors have also prescribed at-home, non-invasive stimulators for severe headaches. However, there is not substantial evidence that the devices are stimulating the vagus nerve and not other structures near it, said Warren M. Grill, Ph.D., professor of biomedical engineering at Duke.
For the experimental model, mice with inflammation received one nerve-stimulating treatment lasting several minutes. The researchers monitored for signs of vagus nerve activation, such as a slower heart rate and twitching of muscles around the larynx, and found improved cognitive outcomes and reduced brain inflammation after this treatment.
“This minimally invasive approach is already exceedingly benign, but in the long term it would be desirable to have an entirely non-invasive approach and we are beginning that work,” Grill said.
The Latest on: Vagus nerve stimulation
via Google News
The Latest on: Vagus nerve stimulation
- Biomarker May Flag Response to Novel AF Interventionon November 26, 2020 at 11:02 am
Neuromodulation of the tragus nerve using a TENS-type device has been shown to reduce AF burden. A biomarker, neuropeptide Y, may flag who will or won't respond to this intervention.
- Global Neuroprosthetics Market 2020 Business Strategies – Medtronic, Abbott, Cochlear, Boston Scientific, Livanova, Second Sighton November 25, 2020 at 10:55 pm
Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation,and Transcranial Magnetic Stimulation), andby Application (Motor Neuron Disorders, Physiological Disorders, and Cognitive ...
- Vagus Nerve Stimulator Market to Record an Exponential CAGR in the upcoming yearson November 24, 2020 at 2:39 pm
Pune, New York, USA, November 24 2020 (Wiredrelease) Research Dive –:The global vagus nerve stimulator market is estimated to surpass $1,334.8 million by 2027, exhibiting a CAGR of 11.4% from 2020 to ...
- Will CMS Reverse Its Stance on LivaNova's VNS for Depression?on November 22, 2020 at 4:00 pm
CMS said it will reconsider its national coverage determination for LivaNova's Vagus Nerve Stimulation (VNS) Therapy for treatment-resistant depression (TRD). LivaNova's implantable VNS devices are ...
- Study to address post-COVID neurological and psychiatric symptoms using at-home format 17 Novemberon November 16, 2020 at 3:06 pm
New studies show that COVID can affect patients during two distinct phases of the disease process: the acute stage, characterized by fever, heart or ...
- Brain Stimulation Can Alter Immune Response by Targeting Vagus Nerveon November 13, 2020 at 4:30 am
Researchers discovered that a small cluster of neurons within the brain is responsible for controlling the body’s immune response and the release of cytokines, which leads to inflammation in the body.
- Brainstem Neurons Identified as Regulator of Inflammationon November 10, 2020 at 8:01 am
of the vagus are responsible for communicating cytokine-inhibiting signals to the splenic nerve. By controlling these neural signals through selective stimulation, researchers can turn off cytokines ...
- Brainstem Neurons Identified as Regulator of Inflammationon November 10, 2020 at 8:00 am
of the vagus are responsible for communicating cytokine-inhibiting signals to the splenic nerve. By controlling these neural signals through selective stimulation, researchers can turn off ...
- MRI Helps to Optimize Vagus Nerve Stimulation for GI Conditionson November 7, 2020 at 4:00 pm
Vagus nerve stimulation to address various gastrointestinal conditions is already an approved FDA therapy. While effective in many people, it is hard to understand the mechanism of such treatment ...
via Bing News